Three cases of non-surgical treatment of stent loss during percutaneous coronary intervention

Byung-Ju Shim1, Jong-Min Lee, Seung-Jae Lee

  • 1Division of Cardiology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Korean Circulation Journal
|November 20, 2010
PubMed

Insights

Stent loss during percutaneous coronary intervention is rare but serious. This report details three successful non-surgical treatments for this complication in ischemic heart disease patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Devices

Background:

  • Percutaneous coronary intervention (PCI) with stenting is a common treatment for ischemic heart disease.
  • Stent loss during PCI is a rare but potentially severe complication.
  • Complications of stent loss include bleeding, stent embolism, acute myocardial infarction, and death.

Purpose of the Study:

  • To report on three cases of stent loss during PCI.
  • To demonstrate the successful application of non-surgical methods for treating stent loss.
  • To highlight the importance of prompt and appropriate management of stent loss.

Main Methods:

  • Review of three clinical cases involving stent loss during PCI.
  • Application of three distinct non-surgical treatment strategies.
  • Detailed documentation of procedural outcomes and patient follow-up.

Main Results:

  • All three cases of stent loss were successfully managed without surgical intervention.
  • The non-surgical methods employed were effective in resolving the stent loss complication.
  • Patients experienced favorable outcomes following the non-surgical treatments.

Conclusions:

  • Non-surgical interventions can be effective in managing rare cases of stent loss during PCI.
  • Prompt diagnosis and appropriate non-surgical treatment are crucial for favorable outcomes.
  • These cases suggest alternative management strategies for stent loss, potentially avoiding more invasive procedures.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...